New device could spot nerve damage early in kids getting chemo
NCT ID NCT04786977
First seen Apr 12, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study aims to create a simple, objective tool to detect nerve damage caused by the chemotherapy drug vincristine in children and teens. Researchers will test a new device on 40 patients aged 6-18 who have received vincristine for leukemia. The goal is to catch nerve problems early, so doctors can adjust treatment to reduce long-term side effects while still fighting the cancer effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Health System
RECRUITINGWashington D.C., District of Columbia, 20010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.